Literature DB >> 20529

[Prevention and therapy of chronic cor pulmonale (author's transl)].

H Herzog, C Kopp, A Perruchoud.   

Abstract

First prophylactic and therapeutic possibilities in cor pulmonale are shown on the basis of its pathogenesis. Our own results illustrate the effect of therapy of the underlying lung disease and of the concomitant respiratory insufficiency on the pulmonary arterial hypertension. The relationship between pulmonary artery pressure (PAp), arterial oxygen tension, forced expiratory volume of 1 second (FEV1%VC) and slow inspired viral capacity (VC) is analysed. In obstructive respiratory disorders the PAp rises when FEV1 falls below 40% of VC, in restrictive disorders when VC falls below 70% of predicted rate. 27 patients with chronic obstructive lung disease were treated with bronchodilator aerosols by intermittent positive pressure breathing (IPPB) during 2 years after a control period of 2 years: VC and FEV1 improved, the increase of total lung capacity and the deterioration of arterial blood gases came to a halt. The elevated PAp was always significantly reduced by oxygen therapy or IPPB or the combination of both. Finally, the rationale for avoiding physical stress in established cor pulmonale is illustrated: in healthy men PAp increases by less than 20% when cardiac output is doubled. In patients with cor pulmonale PAp rises to three times the initial value under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20529     DOI: 10.1007/BF01651265

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  32 in total

1.  THE INFLUENCE OF HYDROGEN ION CONCENTRATION AND HYPOXIA ON THE PULMONARY CIRCULATION.

Authors:  Y ENSON; C GIUNTINI; M L LEWIS; T Q MORRIS; M I FERRER; R M HARVEY
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  EFFECT OF BREATHING OXYGEN UPON CARDIAC OUTPUT, HEART RATE, VENTILATION, SYSTEMIC AND PULMONARY BLOOD PRESSURE IN PATIENTS WITH CHRONIC LUNG DISEASE.

Authors:  J E COTES; Z PISA; A J THOMAS
Journal:  Clin Sci       Date:  1963-10       Impact factor: 6.124

3.  EFFECTS OF ACIDOSIS ON RESPIRATORY FUNCTION.

Authors:  Y ENSON
Journal:  Ann N Y Acad Sci       Date:  1965-03-24       Impact factor: 5.691

4.  Cardiorespiratory failure in kyphoscoliosis.

Authors:  E H BERGOFSKY; G M TURINO; A P FISHMAN
Journal:  Medicine (Baltimore)       Date:  1959-09       Impact factor: 1.889

5.  Chemical control of the distribution of the pulmonary blood flow.

Authors:  G LILJESTRAND
Journal:  Acta Physiol Scand       Date:  1958-12-15

6.  Enlargement of the bronchial arteries, and their anastomoses with the pulmonary arteries in bronchiectasis.

Authors:  A A LIEBOW; M R HALES; G E LINDSKOG
Journal:  Am J Pathol       Date:  1949-03       Impact factor: 4.307

7.  [Are the primary vascular forms of chronic pulmonary heart disease becoming more common?].

Authors:  H P Gurtner; M Gertsch; C Salzmann; M Scherrer; P Stucki; F Wyss
Journal:  Schweiz Med Wochenschr       Date:  1968-10-12

8.  Hemodynamic effects of aminophylline in heart failure.

Authors:  J O Parker; G Kelly; R O West
Journal:  Am J Cardiol       Date:  1966-02       Impact factor: 2.778

9.  Hemodynamic effects of aminophylline in cor pulmonale.

Authors:  J O Parker; K Kelkar; R O West
Journal:  Circulation       Date:  1966-01       Impact factor: 29.690

10.  Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes.

Authors:  A M Rudolph; S Yuan
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.